Ultragenyx Pharmaceutical, Inc. (RARE)

23.88 -0.82 (-3.32%) USD  |  NASDAQ  |  Feb 09, 16:00
23.80 -0.08 (-0.34%) After-Hours: 20:00
More

Ultragenyx Pharmaceutical Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for RARE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Johnson & Johnson Upgrade
CorMedix, Inc. Upgrade
Insmed, Inc. Upgrade
Apellis Pharmaceuticals, Inc. Upgrade